Head-to-head · WeighScore
NP2GO vs PlexusDx
By GLP-1 ScorecardUpdated
Score comparison
NP2GO has the higher recorded score — 80.2/100 to 67.7/100.
NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | NP2GO | PlexusDx |
|---|---|---|
| WeighScore | 80.2/100 | 67.7/100 |
| Grade | B− | C |
| Site position | #37 | #176 |
| Semaglutide | $150/mo | $149/mo (starting dose, compounded) |
| Tirzepatide | $250/mo | $249/mo (starting dose, compounded) |
| Coverage | 40 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #37 · B−
Strengths
- Both molecules
- 40-state footprint
- Transparent listed pricing
What to consider
- Independent LegitScript certification has not been verified for this review
- Upper-mid pricing ($150/$250)
- Not all 50 states
Site position #176 · C
Strengths
- Licensed providers available in all 50 states
- Range of options including low-cost microdose GLP-1 from $129/mo
- Optional Precision Peptide genetic panel adds a personalization angle
- Independent clinician review via state-licensed telehealth platform
- Compounded medications from state-licensed pharmacies
What to consider
- Compounded medications only; no FDA-approved brand options
- Specific compounding pharmacies not named
- Genetic-panel upsell may not add clinical value for everyone
- Tirzepatide pricing from $249/mo is higher than budget rivals
- No insurance accepted
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.